As of 2025-09-19, the EV/EBITDA ratio of G1 Therapeutics Inc (GTHX) is -11.57. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GTHX's latest enterprise value is 406.48 mil USD. GTHX's TTM EBITDA according to its financial statements is -35.15 mil USD. Dividing these 2 quantities gives us the above GTHX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.7x - 14.7x | 13.9x |
| Forward P/E multiples | 16.6x - 34.2x | 19.2x |
| Fair Price | (11.59) - (10.35) | (11.58) |
| Upside | -262.0% - -244.7% | -261.9% |
| Date | EV/EBITDA |